Danish pharmaceutical giant Novo Nordisk announced Thursday that federal health regulators have given the green light to an increased strength version of its weight loss medication Wegovy.
The Food and Drug Administration’s approval covers the higher-dose formulation for helping patients shed excess pounds and keep the weight off over extended periods, according to the company’s announcement.
The enhanced dosage represents an expansion of treatment options for the popular weight management drug that has gained significant attention in recent years.
